The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Increased fetal loss in women with heritable thrombophilia
Abstract
Background A successful outcome of pregnancy requires an efficient uteroplacental vascular system. Since this system may be compromised by disorders of haemostasis associated with a prothrombotic state, we postulated that maternal thrombophilia might be a risk factor for fetal loss. We studied the relation between heritable thrombophilic defects and fetal loss in a cohort of women with factor V Leiden or deficiency of antithrombin, protein C, or protein S.Methods We studied 1384 women enrolled in the European Prospective Cohort on Thrombophilia (EPCOT). Of 843 women with thrombophilia 571 had 1524 pregnancies; of 541 control women 395 had 1019 pregnancies. The controls were partners of male members of the EPCOT cohort or acquaintances of cases. We analysed the frequencies of miscarriage (fetal loss at or before 28 weeks of gestation) and stillbirth (fetal loss after 28 weeks of gestation) jointly and separately.Findings The risk of fetal loss was increased in women with thrombophilia (168/571 vs 93/395; odds ratio 1.35 [95% Cl 1.01-1.82]). The odds ratio was higher for stillbirth than for miscarriage (3.6 [1.4-9.4] vs 1.27 [0.94-1.71]). The highest odds ratio for stillbirth was in women with combined defects (14.3 [2.4-86.0]) compared with 5.2 (1.5-18.1) in antithrombin deficiency, 2.3 (0.6-8.3) in protein-C deficiency, 3.3 (1.0-11.3) in protein-S deficiency, and 2.0 (0.5-7.7) with factor V Leiden. The corresponding odds ratios for miscarriage in these subgroups were 0.8 (0.2-3.6), 1.7 (1.0-2.8), 1.4 (0.9-2.2), 1.2 (0.7-1.9), and 0.9 (0.5-1.5). Significantly more pregnancy terminations had been done in women with thrombophilia than in controls (odds ratio 2.9 [1.8-4.8]); this discrepancy was apparent in nine of 11 participating centres and for all thrombophilia subgroups.Interpretation Women with familial thrombophilia, especially those with combined defects or antithrombin deficiency, have an increased risk of fetal loss, particularly stillbirth. Our findings have important implications for therapy and provide a rationale for clinical trials of thromboprophylaxis for affected women with recurrent fetal loss.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Protein S deficiency has not demonstrated a consistent association with recurrent first trimester miscarriage, but has shown an association with second trimester.41,44,45”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [44]
In the citing paper
“Protein C deficiency has not shown a consistent association with recurrent miscarriage.41,44”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [44]
In the citing paper
“Antithrombin deficiency is the rarer yet most thrombogenic mutation; however, the European prospective cohort study on thrombophilia (EPCOT) found only a possible association with sporadic miscarriage 44 while a subsequent meta-analysis did not.41”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [44]
Citations
Cites
Mutation in blood coagulation factor V associated with resistance to activated protein C
Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., van der Velden, P. A., & Reitsma, P. H. (1994) · Nature · doi:10.1038/369064a0 · Cited by 3,783
Self-citationDahlbäck, B., Carlsson, M., & Svensson, P. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.1004 · Cited by 1,945
Koster, T., Vandenbroucke, J., Rosendaal, F., de Ronde, H., Briët, E., & Bertina, R. (1993) · The Lancet · doi:10.1016/s0140-6736(05)80081-9 · Cited by 1,239
Self-citationWorld distribution of factor V Leiden
Rees, D. C., Cox, M., & Clegg, J. B. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91803-5 · Cited by 1,156
Rosendaal, F., Koster, T., Vandenbroucke, J., & Reitsma, P. (1995) · Blood · doi:10.1182/blood.v85.6.1504.bloodjournal8561504 · Cited by 1,004
Self-citationRecurrent miscarriage I: definition and epidemiology
Stirrat, G. M. (1990) · The Lancet · doi:10.1016/0140-6736(90)92159-f · Cited by 600
Koeleman, B., Reitsma, P., Allaart, C., & Bertina, R. (1994) · Blood · doi:10.1182/blood.v84.4.1031.1031 · Cited by 445
Healy, A. M., Rayburn, H. B., Rosenberg, R. D., & Weiler, H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.850 · Cited by 242
Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies
Malia, R. G., Kitchen, S., Greaves, M., & Preston, F. E. (1990) · British Journal of Haematology · doi:10.1111/j.1365-2141.1990.tb07843.x · Cited by 209
Self-citationLupus Anticoagulants, Anticardiolipin Antibodies, and Fetal Loss: A Case–Control Study
Infante-Rivard, C., David, M., Gauthier, R., & Rivard, G.-E. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110103251503 · Cited by 205
Cited by
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Middeldorp, S., Veenstra, D. L., Prabulos, A.-M., & Vandvik, P. O. (2012) · Chest · doi:10.1378/chest.11-2300 · Cited by 1,525
Evaluation and treatment of recurrent pregnancy loss: a committee opinion
(2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.06.048 · Cited by 1,308
Rai, R., & Regan, L. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69204-0 · Cited by 1,227
Increased Frequency of Genetic Thrombophilia in Women with Complications of Pregnancy
Kupferminc, M. J., Eldor, A., Steinman, N., Many, A., Bar-Am, A., Jaffa, A., Fait, G., & Lessing, J. B. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400102 · Cited by 956
Thrombophilic disorders and fetal loss: a meta-analysis
Rey, E., Kahn, S. R., David, M., & Shrier, I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12771-7 · Cited by 872
Metadata
- Authors
- Preston, F., Rosendaal, F., Walker, I., Briët, E., Berntorp, E., Conard, J., Fontcuberta, J., Makris, M., Mariani, G., Noteboom, W., Pabinger, I., Legnani, C., Scharrer, I., Schulman, S., & van der Meer, F.
- Affiliations
- Royal Hallamshire Hospital (GB)
- Glasgow Royal Infirmary (GB)
- Lund University (SE)
- Hôtel-Dieu de Paris (FR)
- Hospital de Sant Pau (ES)
- Sapienza University of Rome (IT)
- Vienna General Hospital (AT)
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- Goethe University Frankfurt (DE)
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1996-10
- Volume
- 348
- Issue
- 9032
- Pages
- 913-916
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W1994709901
- Cited by
- 661
- References
- 10
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 7 · 2023: 12 · 2022: 7 · 2021: 11 · 2020: 12 · 2019: 6 · 2018: 10 · 2017: 13 · 2016: 16 · 2015: 12 · 2014: 21 · 2013: 31 · 2012: 18
- FWCI
- 13.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Keywords
- inherited thrombophilia, fetal death, miscarriage, stillbirth, factor V Leiden, antithrombin deficiency, protein C deficiency, protein S deficiency, pregnancy outcomes, hypercoagulability, abortion, maternal risk factors
- MeSH terms
- Abortion, Spontaneous, Adult, Aged, Aged, 80 and over, Blood Coagulation Disorders, Blood Protein Disorders, Factor V Deficiency, Female, Fetal Death, Humans, Middle Aged, Pregnancy, Recurrence, Risk Factors, Cohort Studies, Case-Control Studies, Protein S Deficiency, Protein C Deficiency, Antithrombin III Deficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased fetal loss in women with heritable thrombophilia. https://app.cochat.ai/papers/10.1016/s0140-6736(96)04125-6
- The paper
- Preston, F., Rosendaal, F., Walker, I., Briët, E., Berntorp, E., Conard, J., Fontcuberta, J., Makris, M., Mariani, G., Noteboom, W., Pabinger, I., Legnani, C., Scharrer, I., Schulman, S., & van der Meer, F. (1996). Increased fetal loss in women with heritable thrombophilia. The Lancet. https://doi.org/10.1016/s0140-6736(96)04125-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.